{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:11:52Z","timestamp":1790017912945,"version":"4.0.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007614","name":"Al Jouf University","doi-asserted-by":"publisher","award":["DGSSR-2023-01-02148"],"award-info":[{"award-number":["DGSSR-2023-01-02148"]}],"id":[{"id":"10.13039\/501100007614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s13346-024-01753-0","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:37:54Z","timestamp":1734017874000},"page":"2565-2580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Intranasal trimethyl chitosan-coated emulsomes containing tizanidine as brain-targeted therapy in spasticity: formulation, optimization, and pharmacokinetic assessment"],"prefix":"10.1007","volume":"15","author":[{"given":"Mohammed H.","family":"Elkomy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia M.","family":"Hendawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa Mohammed","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa S.","family":"Tulbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basmah Nasser","family":"Aldosari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5488-8602","authenticated-orcid":false,"given":"Hussein M.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"2","key":"1753_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s13346-022-01217-3","volume":"13","author":"AM Mohsen","year":"2023","unstructured":"Mohsen AM, et al. Formulation of tizanidine hydrochloride\u2013loaded provesicular system for improved oral delivery and therapeutic activity employing a 23 full factorial design. Drug Deliv Transl Res. 2023;13(2):580\u201392.","journal-title":"Drug Deliv Transl Res"},{"issue":"5","key":"1753_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/02652048.2023.2209651","volume":"40","author":"H Thakkar","year":"2023","unstructured":"Thakkar H, Modi B, Patel B. Intranasal spray of cubosomal tizanidine hydrochloride for brain targeting: in vitro and in vivo characterisation. J Microencapsul. 2023;40(5):366\u201383.","journal-title":"J Microencapsul"},{"issue":"4","key":"1753_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1024\/0301-1526.29.4.269","volume":"29","author":"M Hirai","year":"2000","unstructured":"Hirai M. Prevalence and characteristics of muscle cramps in patients with varicose veins. VASA Zeitschrift fur Gefasskrankheiten. 2000;29(4):269\u201373.","journal-title":"VASA Zeitschrift fur Gefasskrankheiten"},{"key":"1753_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-020-01734-9","volume":"21","author":"S Pramanik","year":"2020","unstructured":"Pramanik S, Thakkar H. Development of solid self-microemulsifying system of tizanidine hydrochloride for oral bioavailability enhancement: In vitro and in vivo evaluation. AAPS PharmSciTech. 2020;21:1\u201311.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"1753_CR5","first-page":"1","volume":"16","author":"J Fudin","year":"2016","unstructured":"Fudin J, Raouf M. A review of skeletal muscle relaxants for pain management. Pract Pain Manag. 2016;16(5):1\u201315.","journal-title":"Pract Pain Manag"},{"issue":"2","key":"1753_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","volume":"28","author":"R Chou","year":"2004","unstructured":"Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004;28(2):140\u201375.","journal-title":"J Pain Symptom Manage"},{"key":"1753_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13311-011-0025-5","volume":"8","author":"AG Rabchevsky","year":"2011","unstructured":"Rabchevsky AG, Kitzman PH. Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury. Neurotherapeutics. 2011;8:274\u201382.","journal-title":"Neurotherapeutics"},{"issue":"3","key":"1753_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.apsb.2011.12.012","volume":"2","author":"MS Pendekal","year":"2012","unstructured":"Pendekal MS, Tegginamat PK. Formulation and evaluation of a bioadhesive patch for buccal delivery of tizanidine. Acta Pharmaceutica Sinica B. 2012;2(3):318\u201324.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"1753_CR9","doi-asserted-by":"publisher","first-page":"123168","DOI":"10.1016\/j.ijpharm.2023.123168","volume":"642","author":"MD Arpa","year":"2023","unstructured":"Arpa MD, et al. Chitosan-based buccal mucoadhesive patches to enhance the systemic bioavailability of tizanidine. Int J Pharm. 2023;642:123168.","journal-title":"Int J Pharm"},{"key":"1753_CR10","first-page":"621","volume":"3","author":"KM Chinnala","year":"2015","unstructured":"Chinnala KM, et al. Formulation and evaluation of mouth dissolving films containing tizanidine hydrochloride. Int J Pharm Res Health Sci. 2015;3:621\u201362.","journal-title":"Int J Pharm Res Health Sci"},{"key":"1753_CR11","unstructured":"Suryawanshi VA et al. Formulation and evaluation of tizanidine hydrochloride mouth dissolving film. Int J Pharma Res Health Sci. 2015;5(3)."},{"issue":"2","key":"1753_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5958\/2231-5713.2015.00012.4","volume":"5","author":"V Harikrishnan","year":"2015","unstructured":"Harikrishnan V, Madhusudhan S, Santhiagu A. Evaluation of a novel, natural badam gum as a sustained release and mucoadhesive component of tizanidine hcl buccal tablets. Asian J Pharm Technol. 2015;5(2):71\u20138.","journal-title":"Asian J Pharm Technol"},{"issue":"12","key":"1753_CR13","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1080\/03639045.2018.1509081","volume":"44","author":"N Shahid","year":"2018","unstructured":"Shahid N, et al. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system. Drug Dev Ind Pharm. 2018;44(12):2061\u201370.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"1753_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/10717544.2016.1245369","volume":"24","author":"FA Moawad","year":"2017","unstructured":"Moawad FA, Ali AA, Salem HF. Nanotransfersomes-loaded thermosensitive in situ gel as a rectal delivery system of tizanidine HCl: preparation, in vitro and in vivo performance. Drug Delivery. 2017;24(1):252\u201360.","journal-title":"Drug Delivery"},{"issue":"2","key":"1753_CR15","first-page":"252","volume":"6","author":"A Misra","year":"2003","unstructured":"Misra A, et al. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003;6(2):252\u201373.","journal-title":"J Pharm Pharm Sci"},{"key":"1753_CR16","first-page":"100206","volume":"6","author":"AS Tulbah","year":"2023","unstructured":"Tulbah AS, et al. Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures. Int J Pharm: X. 2023;6:100206.","journal-title":"Int J Pharm: X"},{"issue":"7","key":"1753_CR17","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/pharmaceutics15071805","volume":"15","author":"MH Elkomy","year":"2023","unstructured":"Elkomy MH, et al. Intranasal nanotransferosomal gel for quercetin brain targeting: I. optimization, characterization, brain localization, and cytotoxic studies. Pharmaceutics. 2023;15(7):1805.","journal-title":"Pharmaceutics"},{"issue":"7","key":"1753_CR18","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/pharmaceutics14071374","volume":"14","author":"EM Eissa","year":"2022","unstructured":"Eissa EM, et al. Intranasal delivery of granisetron to the brain via nanostructured cubosomes-based in situ gel for improved management of chemotherapy-induced emesis. Pharmaceutics. 2022;14(7):1374.","journal-title":"Pharmaceutics"},{"issue":"8","key":"1753_CR19","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3390\/pharmaceutics15082095","volume":"15","author":"MH Elkomy","year":"2023","unstructured":"Elkomy MH, et al. Intranasal nanotransferosomal gel for quercetin brain targeting: II. Antidepressant effect in an experimental animal model. Pharmaceutics. 2023;15(8):2095.","journal-title":"Pharmaceutics"},{"key":"1753_CR20","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.jddst.2019.101304","volume":"54","author":"HM Eid","year":"2019","unstructured":"Eid HM, et al. Transfersomal nanovesicles for nose-to-brain delivery of ofloxacin for better management of bacterial meningitis: Formulation, optimization by Box-Behnken design, characterization and in vivo pharmacokinetic study. J Drug Deliv Sci Technol. 2019;54:101304.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"1753_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/ph15030281","volume":"15","author":"HA Abo El-Enin","year":"2022","unstructured":"Abo El-Enin HA, et al. Lipid nanocarriers overlaid with chitosan for brain delivery of berberine via the nasal route. Pharmaceuticals. 2022;15(3):281.","journal-title":"Pharmaceuticals"},{"key":"1753_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2017.11.047","volume":"270","author":"PC Pires","year":"2018","unstructured":"Pires PC, Santos AO. Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies. J Control Release. 2018;270:89\u2013100.","journal-title":"J Control Release"},{"key":"1753_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jconrel.2022.10.005","volume":"351","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review. J Control Release. 2022;351:923\u201340.","journal-title":"J Control Release"},{"key":"1753_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jddst.2019.02.013","volume":"51","author":"D Gadhave","year":"2019","unstructured":"Gadhave D, et al. Intranasal teriflunomide microemulsion: An improved chemotherapeutic approach in glioblastoma. J Drug Deliv Sci Technol. 2019;51:276\u201389.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"1753_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/pharmaceutics14020410","volume":"14","author":"HA Abo El-Enin","year":"2022","unstructured":"Abo El-Enin HA, et al. Assessment of nasal-brain-targeting efficiency of new developed mucoadhesive emulsomes encapsulating an anti-migraine drug for effective treatment of one of the major psychiatric disorders symptoms. Pharmaceutics. 2022;14(2):410.","journal-title":"Pharmaceutics"},{"key":"1753_CR26","doi-asserted-by":"crossref","unstructured":"H. Ucisik M, B. Sleytr U, Schuster B. Emulsomes meet S-layer proteins: an emerging targeted drug delivery system. Curr Pharm Biotechnol. 2015;16(4):392\u2013405.","DOI":"10.2174\/138920101604150218112656"},{"issue":"5","key":"1753_CR27","first-page":"192","volume":"3","author":"AS Nair","year":"2013","unstructured":"Nair AS, et al. Emulsomes: A novel liposomal formulation for sustained drug delivery. Inte Res J Pharm Appl Sci. 2013;3(5):192\u20136.","journal-title":"Inte Res J Pharm Appl Sci"},{"key":"1753_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2147\/IJN.S342504","volume":"17","author":"HM Eid","year":"2022","unstructured":"Eid HM, et al. Potential Use of Tailored Citicoline Chitosan-Coated Liposomes for Effective Wound Healing in Diabetic Rat Model. Int J Nanomed. 2022;17:555.","journal-title":"Int J Nanomed"},{"issue":"3","key":"1753_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/pharmaceutics14030563","volume":"14","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, et al. Surface-modified bilosomes nanogel bearing a natural plant alkaloid for safe management of rheumatoid arthritis inflammation. Pharmaceutics. 2022;14(3):563.","journal-title":"Pharmaceutics"},{"key":"1753_CR30","unstructured":"Soetaert K. plot3D: Plotting Multi-Dimensional Data, R package version 1.1. 1. 2017."},{"issue":"8","key":"1753_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3390\/pharmaceutics13081197","volume":"13","author":"DS Panda","year":"2021","unstructured":"Panda DS, et al. Berberine Encapsulated Lecithin-Chitosan Nanoparticles as Innovative Wound Healing Agent in Type II Diabetes. Pharmaceutics. 2021;13(8):1197.","journal-title":"Pharmaceutics"},{"issue":"8","key":"1753_CR32","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.xphs.2021.04.020","volume":"110","author":"HM Eid","year":"2021","unstructured":"Eid HM, et al. Novel chitosan-coated niosomal formulation for improved management of bacterial conjunctivitis: a highly permeable and efficient ocular nanocarrier for azithromycin. J Pharm Sci. 2021;110(8):3027\u201336.","journal-title":"J Pharm Sci"},{"issue":"9","key":"1753_CR33","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1080\/10717544.2016.1176086","volume":"23","author":"MH Elkomy","year":"2016","unstructured":"Elkomy MH, et al. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling. Drug Delivery. 2016;23(9):3294\u2013306.","journal-title":"Drug Delivery"},{"issue":"4","key":"1753_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/03639045.2016.1268153","volume":"43","author":"MH Elkomy","year":"2017","unstructured":"Elkomy MH, et al. Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic\u2013pharmacodynamic modeling approach for quantitative prediction of skin absorption. Drug Dev Ind Pharm. 2017;43(4):531\u201344.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"1753_CR35","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1080\/10717544.2022.2110997","volume":"29","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, et al. Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: Improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats. Drug Delivery. 2022;29(1):2694\u2013704.","journal-title":"Drug Delivery"},{"issue":"2","key":"1753_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/03639045.2020.1871005","volume":"47","author":"MH Elkomy","year":"2021","unstructured":"Elkomy MH, et al. Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis. Drug Dev Ind Pharm. 2021;47(2):246\u201358.","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"1753_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/08982104.2019.1570250","volume":"29","author":"J Varshosaz","year":"2019","unstructured":"Varshosaz J, et al. PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2. J Liposome Res. 2019;29(4):383\u201398.","journal-title":"J Liposome Res"},{"key":"1753_CR38","doi-asserted-by":"crossref","unstructured":"Youssef H, et al. The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effects. Int Microbiol. 2024;1\u201313.","DOI":"10.1007\/s10123-024-00534-6"},{"issue":"5","key":"1753_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-019-1371-6","volume":"20","author":"HM Eid","year":"2019","unstructured":"Eid HM, et al. Development, optimization, and in vitro\/in vivo characterization of enhanced lipid nanoparticles for ocular delivery of ofloxacin: the influence of pegylation and chitosan coating. AAPS PharmSciTech. 2019;20(5):1\u201314.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"1753_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0939-6411(03)00024-9","volume":"55","author":"C Callens","year":"2003","unstructured":"Callens C, et al. Rheological study on mucoadhesivity of some nasal powder formulations. Eur J Pharm Biopharm. 2003;55(3):323\u20138.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"1753_CR41","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/pharmaceutics14040863","volume":"14","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, et al. Fabrication and In Vitro\/In Vivo Appraisal of Metronidazole Intra-Gastric Buoyant Sustained-Release Tablets in Healthy Volunteers. Pharmaceutics. 2022;14(4):863.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1753_CR42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijpharm.2006.11.027","volume":"336","author":"F Chen","year":"2007","unstructured":"Chen F, Zhang Z-R, Huang Y. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers. Int J Pharm. 2007;336(1):166\u201373.","journal-title":"Int J Pharm"},{"key":"1753_CR43","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.ijbiomac.2014.10.011","volume":"72","author":"A Ahmad","year":"2015","unstructured":"Ahmad A, et al. Application of Box-Behnken design for ultrasonic-assisted extraction of polysaccharides from Paeonia emodi. Int J Biol Macromol. 2015;72:990\u20137.","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"1753_CR44","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/ijms21124407","volume":"21","author":"WA Banks","year":"2020","unstructured":"Banks WA, et al. Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation. Int J Mol Sci. 2020;21(12):4407.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1753_CR45","doi-asserted-by":"publisher","first-page":"13015","DOI":"10.1021\/acsnano.9b05679","volume":"13","author":"Y Tang","year":"2019","unstructured":"Tang Y, et al. Overcoming the reticuloendothelial system barrier to drug delivery with a \u201cdon\u2019t-eat-us\u201d strategy. ACS Nano. 2019;13(11):13015\u201326.","journal-title":"ACS Nano"},{"issue":"2","key":"1753_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.","journal-title":"Pharmaceutics"},{"issue":"7","key":"1753_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/pharmaceutics12070597","volume":"12","author":"ZA Awan","year":"2020","unstructured":"Awan ZA, et al. The enhanced cytotoxic and pro-apoptotic effects of optimized simvastatin-loaded emulsomes on MCF-7 breast cancer cells. Pharmaceutics. 2020;12(7):597.","journal-title":"Pharmaceutics"},{"issue":"10","key":"1753_CR48","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/pharmaceutics12100956","volume":"12","author":"UA Fahmy","year":"2020","unstructured":"Fahmy UA, et al. The encapsulation of febuxostat into emulsomes strongly enhances the cytotoxic potential of the drug on HCT 116 colon cancer cells. Pharmaceutics. 2020;12(10):956.","journal-title":"Pharmaceutics"},{"key":"1753_CR49","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s12272-015-0630-7","volume":"38","author":"X Zhou","year":"2015","unstructured":"Zhou X, Chen Z. Preparation and performance evaluation of emulsomes as a drug delivery system for silybin. Arch Pharmacal Res. 2015;38:2193\u2013200.","journal-title":"Arch Pharmacal Res"},{"issue":"1","key":"1753_CR50","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1080\/10717544.2022.2149898","volume":"29","author":"AS Eita","year":"2022","unstructured":"Eita AS, et al. Repurposing of atorvastatin emulsomes as a topical antifungal agent. Drug Delivery. 2022;29(1):3414\u201331.","journal-title":"Drug Delivery"},{"issue":"8","key":"1753_CR51","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/j.xphs.2024.03.027","volume":"113","author":"HM Eid","year":"2024","unstructured":"Eid HM, et al. A novel chitosan-coated leciplex loaded with ambrisentan as a possible pulmonary nanosystem: optimization, characterization, and pharmacokinetics assessments. J Pharm Sci. 2024;113(8):2320\u201330.","journal-title":"J Pharm Sci."},{"issue":"18","key":"1753_CR52","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.3390\/nu15183881","volume":"15","author":"F Zhou","year":"2023","unstructured":"Zhou F, et al. The commonly used stabilizers for phytochemical-based nanoparticles: stabilization effects, mechanisms, and applications. Nutrients. 2023;15(18):3881.","journal-title":"Nutrients"},{"issue":"35","key":"1753_CR53","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.2174\/0929867325666180601101859","volume":"25","author":"J Schubert","year":"2018","unstructured":"Schubert J, Chanana M. Coating matters: review on colloidal stability of nanoparticles with biocompatible coatings in biological media, living cells and organisms. Curr Med Chem. 2018;25(35):4553\u201386.","journal-title":"Curr Med Chem"},{"issue":"27","key":"1753_CR54","doi-asserted-by":"publisher","first-page":"16495","DOI":"10.1021\/acs.jpcc.9b00913","volume":"123","author":"HT Phan","year":"2019","unstructured":"Phan HT, Haes AJ. What does nanoparticle stability mean? J Phys Chem C. 2019;123(27):16495\u2013507.","journal-title":"J Phys Chem C"},{"issue":"1","key":"1753_CR55","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1080\/10717544.2022.2110996","volume":"29","author":"HM Aldawsari","year":"2022","unstructured":"Aldawsari HM, et al. Surface-tailoring of emulsomes for boosting brain delivery of vinpocetine via intranasal route: in vitro optimization and in vivo pharmacokinetic assessment. Drug Delivery. 2022;29(1):2671\u201384.","journal-title":"Drug Delivery"},{"issue":"6","key":"1753_CR56","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/pharmaceutics13060783","volume":"13","author":"HM Aldawsari","year":"2021","unstructured":"Aldawsari HM, et al. Lipidic nano-sized emulsomes potentiates the cytotoxic and apoptotic effects of raloxifene hydrochloride in MCF-7 human breast cancer cells: factorial analysis and in vitro anti-tumor activity assessment. Pharmaceutics. 2021;13(6):783.","journal-title":"Pharmaceutics"},{"issue":"3","key":"1753_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/pharmaceutics8030025","volume":"8","author":"SGM Ong","year":"2016","unstructured":"Ong SGM, et al. Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics. 2016;8(3):25.","journal-title":"Pharmaceutics"},{"issue":"12","key":"1753_CR58","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1080\/21645515.2015.1053663","volume":"11","author":"A Farhadian","year":"2015","unstructured":"Farhadian A, Dounighi NM, Avadi M. Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery. Hum Vaccin Immunother. 2015;11(12):2811\u20138.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"1753_CR59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/10717544.2013.822945","volume":"20","author":"MI Alam","year":"2013","unstructured":"Alam MI, et al. Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood. Drug Delivery. 2013;20(6):247\u201351.","journal-title":"Drug Delivery"},{"issue":"8","key":"1753_CR60","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1021\/acs.molpharmaceut.5b00088","volume":"12","author":"A Mistry","year":"2015","unstructured":"Mistry A, Stolnik S, Illum L. Nose-to-brain delivery: investigation of the transport of nanoparticles with different surface characteristics and sizes in excised porcine olfactory epithelium. Mol Pharm. 2015;12(8):2755\u201366.","journal-title":"Mol Pharm"},{"issue":"10","key":"1753_CR61","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1080\/03639045.2018.1483388","volume":"44","author":"P Gieszinger","year":"2018","unstructured":"Gieszinger P, et al. Definition and validation of the Design Space for co-milled nasal powder containing nanosized lamotrigine. Drug Dev Ind Pharm. 2018;44(10):1622\u201330.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"1753_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12989-015-0102-8","volume":"12","author":"C Disdier","year":"2015","unstructured":"Disdier C, et al. Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat. Part Fibre Toxicol. 2015;12(1):1\u201320.","journal-title":"Part Fibre Toxicol"},{"issue":"1\u20132","key":"1753_CR63","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijpharm.2015.05.064","volume":"490","author":"FE Abdelrahman","year":"2015","unstructured":"Abdelrahman FE, et al. Investigating the cubosomal ability for transnasal brain targeting: in vitro optimization, ex vivo permeation and in vivo biodistribution. Int J Pharm. 2015;490(1\u20132):281\u201391.","journal-title":"Int J Pharm"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01753-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01753-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01753-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T13:02:01Z","timestamp":1749042121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01753-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01753-0","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"21 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research procedure received approval from the Local Institutional Animal Ethics Committee at Beni-Suef University (Approval No: 024\u2013030) and adhered to the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors declare that they have thoroughly reviewed the last version of the manuscript and have provided their consent for its submission for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}